BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 26349840)

  • 1. Interpreting Hemoglobin A1C in Combination With Conventional Risk Factors for Prediction of Cardiovascular Risk.
    Jarmul JA; Pignone M; Pletcher MJ
    Circ Cardiovasc Qual Outcomes; 2015 Sep; 8(5):501-7. PubMed ID: 26349840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes Mellitus-Related All-Cause and Cardiovascular Mortality in a National Cohort of Adults.
    Raghavan S; Vassy JL; Ho YL; Song RJ; Gagnon DR; Cho K; Wilson PWF; Phillips LS
    J Am Heart Assoc; 2019 Feb; 8(4):e011295. PubMed ID: 30776949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ASCVD risk stratification modifies the effect of HbA1c on cardiovascular events among patients with type 2 diabetes mellitus with basic to moderate risk.
    Zhang H; Qin L; Sheng CS; Niu Y; Gu H; Lu S; Yang Z; Tian J; Su Q
    BMJ Open Diabetes Res Care; 2020 Jan; 8(1):. PubMed ID: 31958299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-specific differences in association of glycosylated hemoglobin levels with the prevalence of cardiovascular diseases among nondiabetics: the National Health and Nutrition Examination Survey 2005-2018.
    Fan R; Li S; Xue Z; Yang R; Lyu J; He H
    BMC Cardiovasc Disord; 2024 Jun; 24(1):310. PubMed ID: 38898403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing Glycosylated Hemoglobin Thresholds for Development of Cardiovascular Disease by Racial and Ethnic Groups.
    Low CG; Merchant M; Hung YY; Liu YH; Vu J; Pursnani S
    J Am Heart Assoc; 2024 May; 13(10):e033559. PubMed ID: 38761085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Race-ethnic differences in the association of genetic loci with HbA1c levels and mortality in U.S. adults: the third National Health and Nutrition Examination Survey (NHANES III).
    Grimsby JL; Porneala BC; Vassy JL; Yang Q; Florez JC; Dupuis J; Liu T; Yesupriya A; Chang MH; Ned RM; Dowling NF; Khoury MJ; Meigs JB;
    BMC Med Genet; 2012 Apr; 13():30. PubMed ID: 22540250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemoglobin glycation index predicts cardiovascular disease in people with type 2 diabetes mellitus: A 10-year longitudinal cohort study.
    Kim MK; Jeong JS; Yun JS; Kwon HS; Baek KH; Song KH; Ahn YB; Ko SH
    J Diabetes Complications; 2018 Oct; 32(10):906-910. PubMed ID: 30121206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of variability in hemoglobin A1c with cardiovascular diseases and mortality in Chinese patients with type 2 diabetes mellitus - A retrospective population-based cohort study.
    Wan EY; Fung CS; Fong DY; Lam CL
    J Diabetes Complications; 2016; 30(7):1240-7. PubMed ID: 27318537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender differences in clinical outcomes among diabetic patients hospitalized for cardiovascular disease.
    Flink L; Mochari-Greenberger H; Mosca L
    Am Heart J; 2013 Jun; 165(6):972-8. PubMed ID: 23708169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clustering of cardiometabolic risk factors and risk of elevated HbA1c in non-Hispanic White, non-Hispanic Black and Mexican-American adults with type 2 diabetes.
    Okosun IS; Annor F; Dawodu EA; Eriksen MP
    Diabetes Metab Syndr; 2014; 8(2):75-81. PubMed ID: 24907170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycated hemoglobin measurement and prediction of cardiovascular disease.
    ; Di Angelantonio E; Gao P; Khan H; Butterworth AS; Wormser D; Kaptoge S; Kondapally Seshasai SR; Thompson A; Sarwar N; Willeit P; Ridker PM; Barr EL; Khaw KT; Psaty BM; Brenner H; Balkau B; Dekker JM; Lawlor DA; Daimon M; Willeit J; Njølstad I; Nissinen A; Brunner EJ; Kuller LH; Price JF; Sundström J; Knuiman MW; Feskens EJ; Verschuren WM; Wald N; Bakker SJ; Whincup PH; Ford I; Goldbourt U; Gómez-de-la-Cámara A; Gallacher J; Simons LA; Rosengren A; Sutherland SE; Björkelund C; Blazer DG; Wassertheil-Smoller S; Onat A; Marín Ibañez A; Casiglia E; Jukema JW; Simpson LM; Giampaoli S; Nordestgaard BG; Selmer R; Wennberg P; Kauhanen J; Salonen JT; Dankner R; Barrett-Connor E; Kavousi M; Gudnason V; Evans D; Wallace RB; Cushman M; D'Agostino RB; Umans JG; Kiyohara Y; Nakagawa H; Sato S; Gillum RF; Folsom AR; van der Schouw YT; Moons KG; Griffin SJ; Sattar N; Wareham NJ; Selvin E; Thompson SG; Danesh J
    JAMA; 2014 Mar; 311(12):1225-33. PubMed ID: 24668104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HbA1c is an independent predictor of non-fatal cardiovascular disease in a Caucasian population without diabetes: a 10-year follow-up of the Hoorn Study.
    van 't Riet E; Rijkelijkhuizen JM; Alssema M; Nijpels G; Stehouwer CD; Heine RJ; Dekker JM
    Eur J Prev Cardiol; 2012 Feb; 19(1):23-31. PubMed ID: 20517157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemoglobin A1c variability as an independent correlate of cardiovascular disease in patients with type 2 diabetes: a cross-sectional analysis of the renal insufficiency and cardiovascular events (RIACE) Italian multicenter study.
    Penno G; Solini A; Zoppini G; Orsi E; Fondelli C; Zerbini G; Morano S; Cavalot F; Lamacchia O; Trevisan R; Vedovato M; Pugliese G;
    Cardiovasc Diabetol; 2013 Jul; 12():98. PubMed ID: 23829205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New aspects of HbA1c as a risk factor for cardiovascular diseases in type 2 diabetes: an observational study from the Swedish National Diabetes Register (NDR).
    Eeg-Olofsson K; Cederholm J; Nilsson PM; Zethelius B; Svensson AM; Gudbjörnsdóttir S; Eliasson B
    J Intern Med; 2010 Nov; 268(5):471-82. PubMed ID: 20804517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in control of cardiovascular risk factors among US adults with type 2 diabetes from 1999 to 2010: comparison by prevalent cardiovascular disease status.
    Wong ND; Patao C; Wong K; Malik S; Franklin SS; Iloeje U
    Diab Vasc Dis Res; 2013 Nov; 10(6):505-13. PubMed ID: 23975724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One-hour post-load hyperglycemia combined with HbA1c identifies individuals with higher risk of cardiovascular diseases: Cross-sectional data from the CATAMERI study.
    Fiorentino TV; Succurro E; Andreozzi F; Sciacqua A; Perticone F; Sesti G
    Diabetes Metab Res Rev; 2019 Feb; 35(2):e3096. PubMed ID: 30378248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Between Hemoglobin A1c and Development of Cardiovascular Disease in Canadian Men and Women Without Diabetes at Baseline: A Population-Based Study of 608 474 Adults.
    Butalia S; Chu LM; Dover DC; Lau D; Yeung RO; Eurich DT; Senior P; Kaul P
    J Am Heart Assoc; 2024 May; 13(9):e031095. PubMed ID: 38639364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global cardiovascular disease risk assessment in United States adults with diabetes.
    Wong ND; Glovaci D; Wong K; Malik S; Franklin SS; Wygant G; Iloeje U
    Diab Vasc Dis Res; 2012 Apr; 9(2):146-52. PubMed ID: 22377485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic importance of baseline and serial glycated hemoglobin levels in high-risk patients with type 2 diabetes: the Rio de Janeiro Type 2 Diabetes Cohort Study.
    Cardoso CR; Leite NC; Ferreira MT; Salles GF
    Acta Diabetol; 2015 Feb; 52(1):21-9. PubMed ID: 24816865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Premature cardiovascular events and mortality in south Asians with type 2 diabetes in the United Kingdom Asian Diabetes Study - effect of ethnicity on risk.
    Bellary S; O'Hare JP; Raymond NT; Mughal S; Hanif WM; Jones A; Kumar S; Barnett AH
    Curr Med Res Opin; 2010 Aug; 26(8):1873-9. PubMed ID: 20528107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.